136 related articles for article (PubMed ID: 12546713)
21. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
22. Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.
Ban EZ; Lye MS; Chong PP; Yap YY; Lim SYC; Abdul Rahman H
PLoS One; 2017; 12(11):e0187200. PubMed ID: 29121049
[TBL] [Abstract][Full Text] [Related]
23. The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status.
Zheng J; Liu B; Zhang L; Jiang L; Huang B; You Y; Jiang Q; Zhang S; Lu J; Zhou Y
Int J Cancer; 2012 May; 130(9):1981-90. PubMed ID: 21702039
[TBL] [Abstract][Full Text] [Related]
24. Expression of an Epstein-Barr-virus receptor and Epstein-Barr-virus-dependent transformation of human nasopharyngeal epithelial cells.
Shao X; He Z; Chen Z; Yao K
Int J Cancer; 1997 May; 71(5):750-5. PubMed ID: 9180141
[TBL] [Abstract][Full Text] [Related]
25. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms of TLR3 are associated with Nasopharyngeal carcinoma risk in Cantonese population.
He JF; Jia WH; Fan Q; Zhou XX; Qin HD; Shugart YY; Zeng YX
BMC Cancer; 2007 Oct; 7():194. PubMed ID: 17939877
[TBL] [Abstract][Full Text] [Related]
27. [Transporter associated with antigen processing 1 637A/G gene polymorphisms and susceptibility to nasopharyngeal carcinoma in Han population in Yunnan Province, China].
Sui J; Mo Q; Li XJ; Ma J; Ren YX; Gao W; Wang H; Yang J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Mar; 45(3):238-43. PubMed ID: 20450707
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
29. [Association study of chromosome 4 STRs polymorphisms with nasopharyngeal carcinoma].
Guo XC; O'Brien SJ; Winkler C; Scott K; Hutcheson H; David V; Kessing B; Zheng YM; Liao J; Lui Y; Guy de T; Zeng Y
Yi Chuan; 2006 Jul; 28(7):783-90. PubMed ID: 16825163
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
31. Distinct functional regions of the human polymeric immunoglobulin receptor.
Sunagawa K; Omagari D; Nishiyama M; Asano M; Okudera M; Sugitani M; Nemoto N; Komiyama K
Scand J Immunol; 2013 Oct; 78(4):339-44. PubMed ID: 23809084
[TBL] [Abstract][Full Text] [Related]
32. Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome.
Ghandri N; Gabbouj S; Farhat K; Bouaouina N; Abdelaziz H; Nouri A; Chouchane L; Hassen E
Hum Immunol; 2011 Feb; 72(2):150-8. PubMed ID: 20969909
[TBL] [Abstract][Full Text] [Related]
33. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population.
Nong LG; Luo B; Zhang L; Nong HB
DNA Cell Biol; 2009 Oct; 28(10):507-13. PubMed ID: 19622039
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
36. Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.
Coghill AE; Hsu WL; Yang Q; Wang CP; Lou PJ; Yu KJ; Yu G; Diehl SR; Chen CJ; Goldstein AM; Hildesheim A
J Gen Virol; 2018 Sep; 99(9):1268-1273. PubMed ID: 29975184
[TBL] [Abstract][Full Text] [Related]
37. Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
Asian Pac J Cancer Prev; 2005; 6(3):270-5. PubMed ID: 16235985
[TBL] [Abstract][Full Text] [Related]
38. Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk.
Zhou XX; Jia WH; Shen GP; Qin HD; Yu XJ; Chen LZ; Feng QS; Shugart YY; Zeng YX
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):862-6. PubMed ID: 16702361
[TBL] [Abstract][Full Text] [Related]
39. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors.
Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B
Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961
[TBL] [Abstract][Full Text] [Related]
40. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population.
Zhu Y; Xu Y; Wei Y; Liang W; Liao M; Zhang L
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):207-11. PubMed ID: 18289837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
